Clinical Trial Update: MiSaver® Stem Cell Treatment for Heart Attack (Acute Myocardial Infarction) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for MiSaver stem cell treatment in myocardial infarction completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• MiSaver (Stem cell treatment)

Snippet

Sponsor: Honya Medical Inc | Conditions: Myocardial Infarction | Phase 1, Phase 2 | Status: COMPLETED